Real-world data analysis suggests that families with at least one member using Novo Nordisk's GLP‑1 RA for weight management tend to reduce spending on alcohol and cigarettes. JAKARTA, Indonesia, Jan.

The latest investor updates on stocks that are trending on Monday.

Amazon Pharmacy announced it has begun selling Novo Nordisk’s new oral Wegovy pill, offering the weight loss medication for ...

Late Friday, Amazon said eligible customers with commercial insurance could pay as little as $25 for a one-month supply of ...

A new medical treatment could be significant for many people with obesity, as it no longer requires injections.

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

An Ozempic-style weight loss drug will be heavily subsidised for Australians with severe obesity and have experienced a cardiovascular event, like a heart attack or stroke.

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...

Eli Lilly is riding the wave of a booming weight management market. Eli Lilly's tirzepatide, sold under the brand names ...

Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...